Novartis, picture here, is the maker of prostate cancer drug, Pluvicto, which is in such short supply.
Mandatory Credit: Fabrice Coffrini/AFP/Getty Images
Stories this photo appears in:
Men with advanced prostate cancer 'missing months of therapy' amid medication shortage
Doctors across the United States who treat people with advanced prostate cancer can't find supplies of a medicine that may help them live longer.
